Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk - News-Medical.Net

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a n… [+2386 chars]

full article...